CLINICAL_TRIALS
trial_result
· 2015-09-29
Clinical Trial Update: Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study [Phase 3]
Summary
Phase 3 trial update comparing a PCSK9 antibody with placebo in hypercholesterolemia completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2015-09-29